Abiopharma

🔍 Agarwal Amit (Director)

Company: Datadog, Inc. (DDOG)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Acquired 20,000 shares of Class A Common Stock (Direct)
  Date: 2026-07-30 | Code: C | equity_swap_involved: 0 | shares_owned_after: 21,640.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 600 shares of Class A Common Stock at $264.3533 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 21,040.00 | transaction_form_type: 4 | Footnotes: F3, F4, F2
• Sold 2,047 shares of Class A Common Stock at $265.2699 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 18,993.00 | transaction_form_type: 4 | Footnotes: F3, F5, F2
• Sold 6,969 shares of Class A Common Stock at $266.3233 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 12,024.00 | transaction_form_type: 4 | Footnotes: F3, F6, F2
• Sold 7,084 shares of Class A Common Stock at $267.1573 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,940.00 | transaction_form_type: 4 | Footnotes: F3, F7, F2
• Sold 1,700 shares of Class A Common Stock at $268.1159 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,240.00 | transaction_form_type: 4 | Footnotes: F3, F8, F2
• Sold 1,600 shares of Class A Common Stock at $268.9994 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,640.00 | transaction_form_type: 4 | Footnotes: F3, F9, F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-07-30 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 6,541.00 | Footnotes: F10
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-07-30 | Code: H | shares_owned_after: 29,071.00
• Sold 20,000 shares of Class B Common Stock (Derivative)
  Date: 2026-07-30 | Code: C | equity_swap_involved: 0 | shares_owned_after: 230,059.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2
• Holds 593,464 shares of Class B Common Stock (Derivative)
  Date: 2026-07-30 | Code: H | shares_owned_after: 593,464.00 | Footnotes: F1, F1, F1, F10
• Holds 42,976 shares of Class B Common Stock (Derivative)
  Date: 2026-07-30 | Code: H | shares_owned_after: 42,976.00 | Footnotes: F1, F1, F1, F11

Footnotes:

• F1: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.
• F2: Shares are held directly by Agarwal 2018 Family Trust, of which the Reporting Person's spouse is Trustee.
• F3: Shares sold pursuant to a 10b5-1 plan dated March 13, 2026.
• F4: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $263.72 to $264.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
• F5: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $264.75 to $265.74. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
• F6: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $265.75 to $266.73. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
• F7: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $266.75 to $267.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
• F8: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $267.76 to $268.75. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
• F9: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $268.76 to $269.59. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
• F10: Shares are held directly by Agarwal 2019 Family Trust, of which the Reporting Person's spouse is Trustee.
• F11: Shares are held by Reporting Person's spouse.